| Autor: |
Banushree Chandrasekhar Srinivasamurthy, Subhashini Ramamoorthi |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Gynecology and Minimally Invasive Therapy, Vol 13, Iss 3, Pp 141-145 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2213-3070 |
| DOI: |
10.4103/gmit.gmit_13_23 |
| Popis: |
Ovarian cancer is one of the most common cancers with a high mortality rate among females worldwide. The understanding of the pathogenesis of the disease is highly important to provide personalized therapy to the patients. Ovarian cancer is as heterogeneous as colon and breast cancer which makes it difficult to treat. The development of gene signature is the only hope in providing targeted therapy to improve the survival of ovarian cancer patients. Malignant epithelial carcinomas are the most common cancers of the ovary with different histological and molecular subtypes and clinical behavior. The development of precursor lesions of ovarian carcinoma in the tubes and endometrium has provided a new dimension to the origin of ovarian cancers. The clinical utility of various gene signatures may not be logical unless validated. Validated gene signatures can aid the clinician in deciding the appropriate line of treatment. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
